View Full Version : News you can use
- FDA approves ella™ tablets for prescription emergency contraception
- FDA Proposes Withdrawal of Low Blood Pressure Drug
- U.S. Marshals seize food from rodent-infested Ga. warehouse
- Urgent Nationwide Egg Recall
- Urgent Nationwide Frozen Mamey Fruit Products Recall
- Study: Presence of murine leukemia virus found in CFS Patients, others
- FDA Warns of Possible Dangers from Portable Foot-Tanning Device
- FDA releases guidance on federal menu labeling requirements
- FDA Warns Consumers to Avoid TimeOut Capsules
- Are there any strategies that Fox News uses to achieve its domination of cable news?
- FDA launches new organizational performance management system
- FDA seeks court order against Michigan dairy
- FDA cautions consumers about Estrella Family Creamery cheeses
- FDA: New warnings required on use of gadolinium-based contrast agents
- FDA acts against 5 electronic cigarette distributors
- FDA approves pediatric use of chemical poisoning treatment
- FDA approves new drug for gout
- FDA issues new dosing guide for children using Valcyte
- Forest Pharmaceuticals agrees to guilty plea for violating FDA laws
- FDA approves devices for left bundle branch block patients
- FDA , U. of Md., train Bangladeshis on aquaculture safety
- FDA approves devices for heart failure patients
- FDA hosts Middle East and North Africa food safety experts
- FDA reviewing preliminary safety information on Actos (pioglitazone)
- FDA approves first oral drug to reduce MS relapses
- FDA significantly restricts access to the diabetes drug Avandia
- FDA approves combination contraceptive containing a folate
- FDA issues final rule on safety information during clinical trials
- FDA warns three companies to stop making unproven claims on mouth rinses
- NIH and FDA announce awards to advance regulatory science
- Deaths prompt CPSC, FDA warning on infant sleep positioners
- FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine
- Can you use news papers for bunny bedding?
- FDA schedules public hearing on Biologics Price Competition and Innovation Act
- FDA awards nearly $3 million for TB research
- FDA Issues Regulatory Science Report
- FDA awards $904,000 to Pan American Health Organization for information ?hub?
- FDA seeks to stop juice company’s processing, distribution
- FDA: Potentially harmful stimulant found in Slimming Beauty capsules
- Abbott Laboratories agrees to withdraw its obesity drug Meridia
- FDA approves injectable drug to treat opioid-dependent patients
- FDA schedules third orphan drug workshop for Nov. 4-5, 2010
- FDA: Possible increased risk of thigh bone fracture with bisphosphonates
- Government takes action against Montana drug manufacturer
- FDA issues warnings to marketers of unapproved ?chelation? products
- FDA participates in ?International Internet Week of Action?
- FDA Determines Knee Device Should Not Have Been Cleared for Marketing
- FDA approves Botox to treat chronic migraine
- FDA Issues Warning Letter to Wright County Egg
- FDA Authorizes Hillandale Farms to Begin Shipping Fresh Shell Eggs
- FDA Provides Update on LASIK Quality of Life Collaboration Project Status
- FDA approves Pradaxa to prevent stroke in people with atrial fibrillation
- FDA: Include warnings on risk for class of prostate cancer drugs
- New Label Changes for Commonly Prescribed HIV Drug Invirase
- FDA Heightens Focus on Retail Food Safety
- Hyland’s Teething Tablets may pose a risk to children
- FDA laboratory receives accreditation
- Federal government takes action against Tennessee food distributor
- Federal Government has seized Tri-Med Labs drug products
- FDA awards $18.5 million in grants for food and feed safety
- U.S. Marshals seize FDA-regulated food stored at rodent-infested warehouse in Georgia
- FDA approves additional medical indication for Sprycel
- FDA approves Latuda to treat schizophrenia in adults
- FDA Approves Teflaro for Bacterial Infections
- NOAA and FDA Announce Chemical Test for Dispersant in Gulf Seafood
- FDA approves new indication for Afinitor
- FDA, University of Rochester announce partnership for new drug products
- FDA reclassifies certain digital mammography devices today
- FDA, USDA, Cornell University announce alliance for produce safety
- FDA, CDC, and Costco warn consumers to avoid Bravo Farms Dutch Style Gouda cheese
- FDA clears Cymbalta to treat chronic musculoskeletal pain
- FDA, State of Maryland, and Baugher Enterprise warn consumers to avoid Baugher?s Appl
- FDA working to prevent radiation overdoses during CT scans
- FDA: Majority of drug and biological product makers meeting postmarketing requirement
- Pharmaceutical Company Lawyer Charged with Obstruction and Making False Statements
- FDA Approves Egrifta to Treat Lipodystrophy in HIV Patients
- FDA: Lot of Mauri Gorgonzola cheese positive for E. coli 0157:H7
- FDA Urges Consumers to be ‘Smart’ about Antibiotic Use
- FDA launches initiative to develop innovative external defibrillators
- FDA approves new treatment option for late-stage breast cancer
- FDA Warning Letters issued to four makers of caffeinated alcoholic beverages
- Xanodyne agrees to withdraw propoxyphene from the U.S. market
- FDA approves Xgeva to help prevent cancer-related bone injury
- FDA warns consumers not to use Vigor-25
- FDA Permits Wright County Egg to begin shipping shell eggs to consumers
- FDA issues guidance on public comment procedures at advisory committee meetings
- FDA warns consumers to avoid Man Up Now capsules
- U.S. Marshals seize FDA-regulated food stored at rodent-infested warehouse in New Mex
- FDA says Tessalon liquid cough capsules pose risk for young children
- FDA: Tainted products marketed as dietary supplements potentially dangerous
- FDA begins process to remove breast cancer indication from Avastin label
- FDA: Consumers should not eat Sally Jackson cheese due to risk of Escherichia coli O1
- FDA announces recall of Abbott glucose test strips
- FDA: Gardasil approved to prevent anal cancer
- FDA: Rolf’s Patisserie recalling all desserts made after November 1
- FDA: Don?t Eat Tiny Greens Brand Alfalfa Sprouts or Spicy Sprouts
- FDA warns consumers not to use Fruta Planta weight loss products
- FDA to require substantial equivalence reviews for new tobacco products
- FDA launches website to help regulated industries save time, resources
- FDA inspects retailers in Miss.; issues warning letters for illegal tobacco sales to
- FDA warns public of continued extortion scam by FDA impersonators
- FDA approves opioid analgesic to help cancer patients manage pain
- FDA limits acetaminophen in prescription combination products; requires liver toxicit
- U.S. Marshals seize dental devices from Florida manufacturer
- FDA seeks to halt processing, distribution at New York juice company
- Federal government obtains permanent injunction against Deltex Pharmaceuticals Inc.
- FDA Approves Head Lice Treatment for Children and Adults
- FDA to improve most common review path for medical devices
- Maine seafood processor enters into consent decree with FDA
- FDA approves Viibryd to treat major depressive disorder
- FDA review indicates possible association between breast implants and a rare cancer
- Fourth FDA orphan drug designation workshop scheduled for Feb. 28 - March 1, 2011
- FDA reminds health care professionals about safe use of non-sterile alcohol prep pads
- FDA approves drug to reduce risk of preterm birth in at-risk pregnant women
- FDA clears first diagnostic radiology application for mobile devices
- FDA orders postmarket surveillance of certain TMJ implants
- FDA launches Medical Device Innovation Initiative
- FDA approves 1st pacemaker designed to work safely during some MRI exams
- FDA approves first 3-D mammography imaging system
- FDA clears test to help patients with kidney transplants
- FDA finalizes regulation for certain software, hardware used with medical devices
- FDA seeks to invest in foodborne illness prevention, medical product safety and count
- U.S. Marshals seize Auralgan Otic Solution
- FDA approves product to prevent bleeding in people with rare genetic defect
- FDA warns against certain uses of asthma drug terbutaline for preterm labor
- FDA permits marketing of first test for most common cause of gastroenteritis outbreak
- Advanced genomic test helps trace sources of foodborne illness outbreak
- FDA and Georgetown University Medical Center announce partnership
- FDA: U.S. Marshals seize food products at Tennessee company
- FDA approves Edarbi to treat high blood pressure
- FDA approves new drug to treat chronic obstructive pulmonary disease
- FDA prompts removal of unapproved drugs from market
- FDA: Risk of oral birth defects in children born to mothers taking topiramate
- FDA modifies boxed warning for pulmonary arterial hypertension drug Letairis
- FDA: E. coli O157:H7 cases linked to hazelnuts
- FDA approves Benlysta to treat lupus
- FDA, Justice Department take action against McNeil-PPC Inc.
- FDA approves device to maintain blood flow during artery bypass brain surgery
- Maryland sprout processor enters into consent decree with the FDA
- FDA approves imaging agent for central nervous system scans
- FDA, EMA announce pilot for parallel assessment of Quality by Design applications
- FDA: Michigan heart-lung bypass machine manufacturer enters into consent decree
- FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of ag
- FDA approves new treatment for a type of late-stage skin cancer
- FDA Warns Consumers to Stop Using Soladek Vitamin Solution
- FDA Issues Statement on Makena
- JOINT EPA/FDA STATEMENT: Update on Ongoing Monitoring
- FDA proposes draft menu and vending machine labeling requirements, invites public to
- FDA launches consumer-friendly Web search for consumers during recalls
- FDA acts to prevent contamination problems with Triad antiseptic products
- FDA approves new device to treat brain aneurysms
- FDA approves new treatment for rare form of thyroid cancer
- FDA approves Horizant to treat restless legs syndrome
- FDA clears test for bacteria that can cause serious intestinal disease
- FDA permits marketing of first test to help diagnose dengue fever
- FDA clears single-use antibacterial surgical respirator
- FDA approves new treatment for large brain aneurysms
- FDA approves new medical device for form of brain cancer
- FDA approves Actemra to treat rare form of juvenile arthritis
- FDA approves Rituxan to treat two rare disorders
- FDA 'Strategic Priorities 2011 - 2015' Now Available
- FDA warns companies to stop making MRSA claims for over-the-counter products
- FDA approves the first vaccine to prevent meningococcal disease in infants and toddle
- FDA seeks permanent injunction against Pennsylvania dairy
- FDA requests seizure of adulterated breaded seafood at Wisconsin firms
- FDA approves Zytiga for late-stage prostate cancer
- FDA looks to improve design and cleaning instructions for reusable medical devices
- FDA approves new treatment for Type 2 diabetes
- FDA, FTC act to remove fraudulent STD products from the market
- FDA issues first new rules under Food Safety Modernization Act
- FDA issues final guidance for liquid OTC drug products with dispensing devices
- FDA approves new treatment for rare type of pancreatic cancer
- FDA clears first test to quickly diagnose and distinguish MRSA and MSSA
- FDA expands approved use for carotid stent
- FDA requests input on development of user fee program for biosimilar and interchangea
- Consumers warned to avoid eating oysters from area 1642 in Apalachicola Bay, Florida
- FDA seeks permanent injunction against Tennessee food warehouses, owner
- FDA: No compre medicamentos comercializados como suplementos nutricionales antimicrob
- FDA: Don’t buy drugs marketed as antimicrobial dietary supplements
- FDA warns about counterfeit ExtenZe dietary supplements
- FDA approves Victrelis for Hepatitis C
- FDA clears first test for recent infection with toxoplasmosis parasite
- FDA approves new HIV treatment
- FDA approves Sutent for rare type of pancreatic cancer
- United States requests seizure of adulterated cheese products at Wisconsin company
- FDA clears first test to diagnose Q fever in military serving overseas
- FDA: Do not feed SimplyThick to premature infants
- FDA approves Incivek for hepatitis C
- FDA takes action against illegal marketing of tobacco products
- FDA to make enforcement and compliance activities accessible online
- FDA seeks comment on preventive controls against foodborne illness
- FDA approves injectable gel to treat fecal incontinence
- FDA approves treatment for Clostridium difficile infection
- FDA seeks injunction concerning uneviscerated seafood and other fish at Minnesota com
- FDA: Breast thermography not a substitute for mammography
- FDA: Treatment with angiotensin receptor blockers for high blood pressure does not in
- FDA statement on E. coli O104 outbreak in Europe
- FDA seizes elderberry juice concentrate at Kansas company
- FDA: DDS probiotic products seized
- FDA announces new safety recommendations for high-dose simvastatin
- FDA: Pfizer will voluntarily suspend sale of animal drug 3-Nitro
- FDA takes ‘first step’ toward greater regulatory certainty around nanotechnology
- FDA clears new system to perform simultaneous PET, MRI scans
- FDA approves redesigned labels for some Merck drugs
- Federal government takes action against drug manufacturer and distributor
- FDA approves Potiga to treat seizures in adults
- FDA Announces Changes to Better Inform Consumers About Sunscreen
- FDA approves new test to help determine if breast cancer patients are candidates for
- FDA approves first ceramic-on-metal total hip replacement system
- FDA approves Nulojix for kidney transplant patients
- FDA: California seafood handler enters into consent decree
- FDA unveils new global strategy to help ensure safety and quality of imported product
- FDA issues draft guidance for early version of an artificial pancreas system
- FDA examines ways to improve consumer understanding of prescription drug ads
- FDA approves first generic versions of the antibiotic levofloxacin to treat certain i
- HHS RELEASE: FDA unveils final cigarette warning labels
- FDA: Maryland food manufacturer enters into consent decree
- FDA provides updated safety data on silicone gel-filled breast implants
- FDA modifies dosing recommendations for Erythropoiesis-Stimulating Agents
- FDA: Do not eat Evergreen Produce brand alfalfa sprouts or spicy sprouts
- FDA: New York dietary supplement manufacturer enters into consent decree
- FDA, Justice Department take action against California calf hauler
- FDA approves Arcapta Neohaler to treat chronic obstructive pulmonary disease
- FDA issues anti-smuggling strategy and draft guidance on new dietary ingredients
- FDA approves Xarelto to reduce risk of blood clots after hip, knee replacements
- FDA proposes new policy for some diagnostic and radiology devices
- FDA approves Boostrix to prevent tetanus, diphtheria, and pertussis in older people
- FDA seeks comment on proposed policy for diagnostic tests used with targeted drug the
- FDA: Surgical placement of mesh to repair pelvic organ prolapse poses risks
- Foodborne outbreak associated with raw milk from Tucker Adkins Dairy of York S.C.
- FDA approves vaccines for the 2011-2012 influenza season
- FDA outlines oversight of mobile medical applications
- FDA, federal partners develop tools for food-emergency readiness
- FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes
- FDA Center for Drug Evaluation and Research develops strategic science and research a
- Foodborne outbreak potentially associated with papaya distributed by Agromod Produce,
- FDA issues draft guidance on device changes that warrant new premarket review
- Unapproved emergency birth control medicine possibly in U.S. distribution may be inef
- FDA to seek public comment on IOM recommendations
- FDA reopens comment period on proposed ‘gluten-free’ food labeling rule
- FDA, international counterparts report progress on drug inspection collaboration
- FDA approves the first specific treatment for scorpion stings
- FDA, state of Arkansas sign agreement to advance regulatory science
- FDA seeks comment on proposed guidelines for high-quality clinical studies
- FDA proposes guidelines that clarify benefit-risk determinations for medical devices
- FDA approves Zelboraf and companion diagnostic test for late-stage skin cancer
- FDA: Regulatory science plan positions agency to foster innovation through better sci
- FDA approves Adcetris to treat two types of lymphoma
- FDA approves Botox to treat specific form of urinary incontinence
- FDA requests seizure of adulterated seafood at California company
vBulletin® v3.8.4, Copyright ©2000-2012, Jelsoft Enterprises Ltd.